{"podcast":{"title":"JHLT: The Podcast","slug":"jhlt-the-podcast-3498579","podcast_index_feed_id":3498579,"rss_url":"https://thejhlt.libsyn.com/rss","website_url":"http://thejhlt.libsyn.com/website","image_url":"https://static.libsyn.com/p/assets/1/7/d/b/17dbae524013e476/JHLT_PodcastLogo.png","author":"Jessica Burke","episode_count":87,"summary":"The Journal of Heart and Lung Transplantation podcast airs each month and features the JHLT Digital Media Editors in round table talks with the Journal's contributors.","last_synced_at":"2026-06-17T14:18:19.340005+00:00","page_url":"https://stenobird.com/podcast/jhlt-the-podcast-3498579"},"episode":{"title":"Episode 74: Outcomes for CTEPH patients with High Antiphospholipid Antibodies after Pulmonary Endarterectomy","slug":"episode-74-outcomes-for-cteph-patients-with-high-antiphospholipid-antibodies-after-pulmonary-endarterectomy","published_at":"2025-12-17T05:30:00+00:00","page_url":"https://stenobird.com/podcast/jhlt-the-podcast-3498579/episode-74-outcomes-for-cteph-patients-with-high-antiphospholipid-antibodies-after-pulmonary-endarterectomy","show_page_url":"https://stenobird.com/podcast/jhlt-the-podcast-3498579","url":"https://thejhlt.libsyn.com/episode-74-outcomes-for-cteph-patients-with-high-antiphospholipid-antibodies-after-pulmonary-endarterectomy","audio_url":"https://traffic.libsyn.com/secure/thejhlt/JHLT_12_Dec_2025_pt2.mp3?dest-id=2489450","summary":"JHLT: The Podcast returns with an episode discussing the paper, \" High Antiphospholipid Antibody Titers and Outcomes of Pulmonary Endarterectomy: A Single-Center Retrospective Observational Cohort Study ,\" from the December issue of JHLT . They are joined by the first author, Camille Miard, MD , and senior author, François Stéphan, MD, PhD , both from the cardiothoracic intensive care unit at Hôpital Marie Lannelongue in Paris. The discussion explores: Whether antiphospholipid antibody titers could predict postoperative outcomes for CTEPH patients undergoing pulmonary endarterectomy (PEA) How APS patients differed from non-APS patients in the PEA cohort The changes in clinical practice at Marie Lannelongue after the study's findings For the latest studies from JHLT , visit www.jhltonline.org/current , or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt . Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org .","meta_description":"JHLT: The Podcast returns with an episode discussing the paper, \" High Antiphospholipid Antibody Titers and Outcomes of Pulmonary Endarterectomy: A Single…","key_points":[],"chapters":[],"topics":[],"duration_seconds":633,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/jhlt-the-podcast-3498579/episodes/episode-74-outcomes-for-cteph-patients-with-high-antiphospholipid-antibodies-after-pulmonary-endarterectomy/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/jhlt-the-podcast-3498579/episode-74-outcomes-for-cteph-patients-with-high-antiphospholipid-antibodies-after-pulmonary-endarterectomy.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}